DOJ Sues to Seize $25M in Scam Crypto
Federal prosecutors want $25 million back from crypto scammers, but chasing the money is easier than chasing the people who stole it.
Federal prosecutors want $25 million back from crypto scammers, but chasing the money is easier than chasing the people who stole it.
GSK turned a $10.6B buyout into an FDA approval in a week. The real question is whether Jideytro can outrun a rival that's barely moving units.
A five-person biotech licensed Merck's discontinued Intron A ingredient for $31M, then set out to raise $50M before an FDA sign-off.
Consumer advocates just told the Tenth Circuit where a loan is legally 'made' could decide every rent-a-bank fight still pending nationwide.
A Phase 3 flop erased Wainua's blockbuster case, leaving AstraZeneca's $80 billion 2030 goal riding on two coin-flip readouts this year.
A Fed prohibition order just ended James Burns's banking career for good, over inflated appraisals that cost his bank's acquirer real money.
Agios scraps tebapivat after it couldn't beat placebo, leaving mitapivat as its only sickle cell bet against Novo's rival drug, PDUFA Nov. 1.
A Colorado nonprofit tells the en banc Tenth Circuit that roughly 73% of voters already settled this rate-cap fight for out-of-state lenders in 2018.
DOJ cleared Paramount's $110 billion buy of Warner Bros. Discovery, then 12 states froze it anyway, days before an August 3 injunction hearing.
A Texas federal judge sent Scoular's bribe-paying customs broker to prison for 18 months, days after the company's $10M deal went public.
Chris Fall is out as CAISI's chief after 3 months, the second AI safety director to exit in a year, and DC still hasn't named a replacement.
Seoul's record $422 million fine on Coupang draws Washington pushback, as lawmakers question whether Korea is treating the company fairly.
Samsung Biologics pays just a 6% premium for PolyPeptide, its second buyout in eight months and Korea's largest-ever biopharma deal.
Mashinsky pays $10 million personally, but the FTC's $16.5 million settlement is dwarfed by the $4.7 billion judgment against Celsius itself.
Italy's DPA didn't buy WindTre's human-error defense: unguarded internal APIs, not the social engineering, drove the €1.7M penalty.